← Back to Search

Facebook Intervention for Skin Cancer

N/A
Recruiting
Led By Sharon Manne
Research Sponsored by Rutgers, The State University of New Jersey
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Patient does not have a concurrent cancer diagnosis
Patient age at diagnosis 18-39 years
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 5 years
Awards & highlights

Study Summary

This trial studies how well two types of Facebook interventions work in improving skin examination in participants with melanoma and their families. The interventions may help improve total cutaneous examinations, skin self-examinations, and sun protection among those studied.

Who is the study for?
This trial is for melanoma patients diagnosed within the last 5 years, aged 18-39, who've completed treatment at least 3 months ago. They must have internet access, a Facebook account, and be able to understand English. Their family members (aged 18-80) without personal melanoma history can join if they haven't had thorough skin exams recently or often do self-exams or use sun protection.Check my eligibility
What is being tested?
The study tests two Facebook-based interventions: one focused on young melanoma families and another on healthy lifestyles. The goal is to see if these online programs increase skin examinations by patients and their relatives as well as improve their sun protection habits.See study design
What are the potential side effects?
Since this trial involves informational interventions through Facebook rather than medical treatments, there are no direct physical side effects expected from participation in the study.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I do not have any other cancer diagnosis.
Select...
I was diagnosed with my condition between the ages of 18 and 39.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 5 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 5 years for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Total cutaneous examination (TCE)
Secondary outcome measures
Skin Self-exam (Relatives)
Skin
Skin self-exam - Comprehensiveness (Relatives)
+4 more
Other outcome measures
Mediator analyses - (Relatives)
Mediator analyses - Intervention Group
Mediator analyses - Intervention Group - Barriers
+12 more

Trial Design

2Treatment groups
Experimental Treatment
Group I: Arm 2 Healthy Lifestyle Facebook focusing on healthy lifestyleExperimental Treatment2 Interventions
Participants join a secret Healthy Lifestyle Facebook Group and view post messages focusing on healthy lifestyle for 12 weeks.
Group II: Arm 1 Young melanoma Family Facebook focusing on skin cancerExperimental Treatment2 Interventions
Participants join a secret Young melanoma Family Facebook Group and view post messages focusing on skin cancer for 12 weeks.

Find a Location

Who is running the clinical trial?

National Cancer Institute (NCI)NIH
13,662 Previous Clinical Trials
40,924,913 Total Patients Enrolled
4 Trials studying Cutaneous Melanoma
198 Patients Enrolled for Cutaneous Melanoma
Rutgers, The State University of New JerseyLead Sponsor
429 Previous Clinical Trials
63,072 Total Patients Enrolled
Sharon MannePrincipal Investigator - Rutgers Cancer Institute of New Jersey
Rutgers Cancer Institute of New Jersey
4 Previous Clinical Trials
128 Total Patients Enrolled

Media Library

Informational Intervention Clinical Trial Eligibility Overview. Trial Name: NCT03677739 — N/A
Cutaneous Melanoma Research Study Groups: Arm 2 Healthy Lifestyle Facebook focusing on healthy lifestyle, Arm 1 Young melanoma Family Facebook focusing on skin cancer
Cutaneous Melanoma Clinical Trial 2023: Informational Intervention Highlights & Side Effects. Trial Name: NCT03677739 — N/A
Informational Intervention 2023 Treatment Timeline for Medical Study. Trial Name: NCT03677739 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

How many individuals can partake in this trial at any given time?

"Affirmative. Clinicaltrials.gov lists this medical investigation as presently recruiting, with the initial posting on June 3rd 2019 and an update registered in November 2022. The research requires 1160 patients to be enrolled at a single site."

Answered by AI

Are there any openings available for those wishing to participate in the research?

"Affirmative. Clinicaltrials.gov confirms that the trial, originally posted on June 3rd 2019, is actively recruiting participants and 1160 individuals are required from a single location for completion of the study."

Answered by AI

Are the age limits of this trial confined to those over 35 years?

"Eligibility for this trial is limited to individuals between the ages of 18 and 80. There are 56 studies available for minors, while 804 trials can be accessed by those aged 65 or beyond."

Answered by AI

Am I eligible to partake in this investigation?

"This clinical trial is incorporating 1160 individuals, 18 to 80 years of age, with a first degree relative. Participants must match the following prerequisites: PATIENT: Diagnosed between the ages of 18-39; sourced from specified cancer registries or MD Anderson Cancer Center; free of coexisting cancers; equipped with computer and internet access plus a Facebook account; have at least one family member that has consented to participation in the study;; FDR: Age range of 18-80 without any personal history melanoma diagnosis and patient who have finished their treatment 3 months prior."

Answered by AI
~20 spots leftby Jun 2024